AP NEWS

Esperion Therapeutics: 2Q Earnings Snapshot

August 2, 2018

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Thursday reported a loss of $45.7 million in its second quarter.

The Ann Arbor, Michigan-based company said it had a loss of $1.71 per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.77 per share.

Esperion Therapeutics shares have decreased 32 percent since the beginning of the year. The stock has decreased slightly in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR

AP RADIO
Update hourly